Back

dr. N. (Nadia) Haj Mohammad

dr. N. (Nadia) Haj Mohammad

Assistant Professor - medical

Show full profile

Research Output (99)

Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands:A Nationwide Analysis

Daamen Lois A, Groot Vincent P, Besselink Marc G, Bosscha Koop, Busch Olivier R, Cirkel Geert A, van Dam Ronald M, Festen Sebastiaan, Groot Koerkamp Bas, Haj Mohammad Nadia, van der Harst Erwin, de Hingh Ignace H J T, Intven Martijn P W, Kazemier Geert, Los Maartje, Meijer Gert J, de Meijer Vincent E, Nieuwenhuijs Vincent B, Pranger Bobby K, Raicu Mihaela G, Schreinemakers Jennifer M J, Stommel Martijn W J, Verdonk Robert C, Verkooijen Helena M, Molenaar Izaak Quintus, van Santvoort Hjalmar C, 8 Jul 2020, In: Annals of Surgery. 275 , p. 769-775 7 p.

Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer:a prospective study with weekly MRI

Defize Ingmar L, Boekhoff Mick R, Borggreve Alicia S, van Lier Astrid L H M W, Takahashi Noriyoshi, Haj Mohammad Nadia, Ruurda Jelle P, van Hillegersberg Richard, Mook Stella, Meijer Gert J 2 Jul 2020, In: Acta Oncologica. 59 , p. 753-759 7 p.

Intestinal and tumor microbiome analysis combined with metabolomics of the anti-PD-L1 phase II PERFECT trial for resectable esophageal adenocarcinoma

de Clercq Nicolien C., van den Ende Tom, Prodan Andrei, Henegouwen Mark I. van Berge, Gisbertz Suzanne S., Meijer Sybren L., Schokker Sandor, Bergman Jacques J. G. H. M., Mohammad Nadia Haj, Ruurda Jelle P., van Hillegersberg Richard, Mook Stella, van Grieken Nicole C. T., de Gruijl Tanja D., Davids Mark, Bijlsma Maarten F., Hulshof Maarten C. C. M., Van Laarhoven Hanneke W. M., Nieuwdorp Max 20 May 2020, In: Journal of Clinical Oncology. 38

MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma

van Velzen M J M, Derks S, van Grieken N C T, Haj Mohammad N, van Laarhoven H W M 28 Apr 2020, In: Cancer Treatment Reviews. 86 8 p.

Advances in adjuvant therapy of biliary tract cancer:an overview of current clinical evidence based on phase II and III trials

Belkouz A, Wilmink J W, Haj Mohammad N, Hagendoorn J, de Vos-Geelen J, Dejong C H C, Homs M Y V, Groot Koerkamp B, van Gulik T M, van Oijen M G H, Punt C J A, Klümpen H 27 Apr 2020, In: Critical Reviews in Oncology/Hematology. 151 9 p.

Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1):a multicenter stepped-wedge cluster randomized controlled trial

Mackay T M, Smits F J, Latenstein A E J, Bogte A, Bonsing B A, Bos H, Bosscha K, Brosens L A A, Hol L, Busch O R C, Creemers G J, Curvers W L, den Dulk M, van Dieren S, van Driel L M J W, Festen S, van Geenen E J M, van der Geest L G, de Groot D J A, de Groot J W B, Haj Mohammad N, Haberkorn B C M, Haver J T, van der Harst E, Hemmink G J M, de Hingh I H, Hoge C, Homs M Y V, van Huijgevoort N C, Jacobs M A J M, Kerver E D, Liem M S L, Los M, Lubbinge H, Luelmo S A C, de Meijer V E, Mekenkamp L, Molenaar I Q, van Oijen M G H, Patijn G A, Quispel R, van Rijssen L B, Römkens T E H, van Santvoort H C, Schreinemakers J M J, Schut H, Seerden T, Verdonk R C, Wessels F J, van Werkhoven C H, 16 Apr 2020, In: Trials. 21 18 p.

Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort

de Savornin Lohman Elise, de Bitter Tessa, Verhoeven Rob, van der Geest Lydia, Hagendoorn Jeroen, Mohammad Nadia Haj, Daams Freek, Heinz-Josef Klümpen Klümpen, van Gulik Thomas, Erdmann Joris, de Boer Marieke, Hoogwater Frederik, Koerkamp Bas Groot, Braat Andries, Verheij Joanne, Nagtegaal Iris, van Laarhoven Cornelis, van den Boezem Peter, van der Post Rachel, de Reuver Philip 9 Apr 2020, In: Cancers. 12 13 p.

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma:a population-based analysis

Latenstein Anouk E J, Mackay Tara M, Creemers Geert-Jan, van Eijck Casper H J, de Groot Jan Willem B, Haj Mohammad Nadia, Homs Marjolein Y V, van Laarhoven Hanneke W M, Molenaar I Quintus, Ten Tije Bert-Jan, de Vos-Geelen Judith, Besselink Marc G, van der Geest Lydia G M, Wilmink Johanna W, 14 Feb 2020, In: Acta Oncologica. 59 , p. 705-712 8 p.

Increased assessment of HER2 in metastatic gastroesophageal cancer patients:a nationwide population-based cohort study

Dijksterhuis Willemieke P M, Verhoeven Rob H A, Meijer Sybren L, Slingerland Marije, Haj Mohammad Nadia, de Vos-Geelen Judith, Beerepoot Laurens V, van Voorthuizen Theo, Creemers Geert-Jan, van Oijen Martijn G H, van Laarhoven Hanneke W M 11 Jan 2020, In: Gastric Cancer. 23 , p. 579-590 12 p.

Refraining from resection in patients with potentially curable gastric carcinoma

Gertsen Emma C., Brenkman Hylke J.F., Brosens L. A.A., Luijten Josianne C.H.B.M., Mohammad Nadia Haj, Verhoeven Rob H.A., van Hillegersberg Richard, Ruurda Jelle P. 2020, In: European Journal of Surgical Oncology. 47 , p. 1062-1068 7 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not